Bailey Jeffrey Allen has filed 7 insider transactions across 1 company since November 2024.
Most recent transaction: a tax payment of 2716 shares of Aurinia Pharmaceuticals Inc. ($AUPH) on November 21, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 21, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Bailey Jeffrey Allen | Director | F | Common Shares | 2716 | $15.68 | 22,775.0000 | 138,959,000 | 10.65% | 0.00% |
| May 16, 2025 | Aurinia Pharmaceuticals Inc. | $AUPH | Bailey Jeffrey Allen | Director | A | Director Stock Option (right to buy) | 37485 | $0.00 | 37,485.0000 | 146,194,000 | 9999.99% | 0.03% |
| Nov. 21, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Bailey Jeffrey Allen | Director | A | Common Shares | 12135 | $0.00 | 25,491.0000 | 145,651,000 | 90.86% | 0.01% |
| Nov. 21, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Bailey Jeffrey Allen | Director | A | Director Stock Option (right to buy) | 18641 | $0.00 | 18,641.0000 | 145,651,000 | 9999.99% | 0.01% |
| Nov. 8, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Bailey Jeffrey Allen | Director | M | Common Stock | 17913 | $0.00 | 17,913.0000 | 145,651,000 | 9999.99% | 0.01% |
| Nov. 11, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Bailey Jeffrey Allen | Director | S | Common Stock | 4557 | $8.43 | 13,356.0000 | 145,651,000 | 25.44% | 0.00% |
| Nov. 8, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Bailey Jeffrey Allen | Director | M | Restricted Stock Units | 17913 | $0.00 | 0.0000 | 145,651,000 | 100.00% | 0.01% |